
Optimizing Therapy Sequencing in HR+/HER2- or Triple-Negative Breast Cancer
In a conversation with CancerNetwork®, Jade E. Jones, MD, assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and medical oncologist at the Emory Winship Cancer Institute, discussed therapy …